IncyteCARES for OPZELURA Patient Assistance Program
Incyte Corporation · Opzelura
uninsured · Medicare Part D
Patient assistance
Tell us your insurance and household details. We’ll show you every Opzelura assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Opzelura help that still works on Medicare or Medicaid - the programs copay cards leave out.
Opzelura (ruxolitinib) is a topical jak inhibitor (janus kinase 1/2 inhibitor) made by Incyte. It is commonly prescribed for: Atopic dermatitis (eczema), Nonsegmental vitiligo.
At a glance
As of July 2026, mendmeds tracks 3 Opzelura assistance programs, 1 of which is open to patients with no insurance.
As of July 2026, 2 of the 3 Opzelura assistance programs remain open to patients on Medicare, coverage that manufacturer copay cards exclude.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Incyte Corporation · Opzelura
uninsured · Medicare Part D
Incyte Corporation · Opzelura
Patient pays: As little as $0 per tube if commercial plan covers Opzelura; $35 per prescription at participating pharmacies if commercial plan does not cover Opzelura
commercial insurance
PAN Foundation (TotalAssist) · Opzelura
Patient pays: Up to $2,100 guaranteed award; $4,200 maximum award toward out-of-pocket medication costs
commercial insurance · Medicare · underinsured
Common questions
Related drugs